[HTML][HTML] Semaglutide effects on cardiovascular outcomes in people with overweight or obesity (SELECT) rationale and design
DH Ryan, I Lingvay, HM Colhoun, J Deanfield… - American heart …, 2020 - Elsevier
Cardiovascular disease (CVD) is a major cause of morbidity and mortality. Although it has
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
[PDF][PDF] SELECT (Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity) rationale and design
DH Ryan, I Lingvay, MHM Colhoun, J Deanfield… - academia.edu
Cardiovascular disease (CVD) is a major cause of morbidity and mortality. While it has been
widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
DH Ryan, I Lingvay, HM Colhoun… - American heart …, 2020 - scholars.northwestern.edu
Cardiovascular disease (CVD) is a major cause of morbidity and mortality. Although it has
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
DH Ryan, I Lingvay, HM Colhoun… - American Heart …, 2020 - discovery.ucl.ac.uk
Cardiovascular disease (CVD) is a major cause of morbidity and mortality. Although it has
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
DH Ryan, I Lingvay, HM Colhoun… - American heart …, 2020 - pubmed.ncbi.nlm.nih.gov
Cardiovascular disease (CVD) is a major cause of morbidity and mortality. Although it has
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
[PDF][PDF] Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
SS Emerson, SE Kahn, RF Kushner, S Marso, J Plutzky… - 2020 - scholar.archive.org
Cardiovascular disease (CVD) is a major cause of morbidity and mortality. Although it has
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
[PDF][PDF] Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
SS Emerson, SE Kahn, RF Kushner, S Marso, J Plutzky… - 2020 - pure.ed.ac.uk
Cardiovascular disease (CVD) is a major cause of morbidity and mortality. Although it has
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design.
DH Ryan, I Lingvay, HM Colhoun, J Deanfield… - American Heart …, 2020 - europepmc.org
Cardiovascular disease (CVD) is a major cause of morbidity and mortality. Although it has
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
DH Ryan, I Lingvay, HM Colhoun… - American …, 2020 - utsouthwestern.elsevierpure.com
Cardiovascular disease (CVD) is a major cause of morbidity and mortality. Although it has
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
DH Ryan, I Lingvay, HM Colhoun… - American Heart …, 2020 - research.ed.ac.uk
Cardiovascular disease (CVD) is a major cause of morbidity and mortality. Although it has
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …
been widely appreciated that obesity is a major risk factor for CVD, treatments that produce …